Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients-Reference-Cited by-同舟云学术

Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients

Published:2015-06-03 Issue:6 Volume:10 Page:e0128368
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ricciardi Giuseppina Rosaria Rita,Adamo Barbara,Ieni Antonio,Licata Luana,Cardia Roberta,Ferraro Giuseppa,Franchina Tindara,Tuccari Giovanni,Adamo Vincenzo

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference54 articles.

1. Deconstructing the molecular portraits of breast cancer;A Prat;Mol Oncol,2011

2. Management and treatment of triple-negative breast cancer patients from the NEMESI study: an Italian experience;V Adamo;Eur J Cancer,2012

3. Triple-negative breast cancer;WD Foulkes;N Engl J Med,2010

4. Directed therapy of subtypes of triple-negative breast cancer;LA Carey;Oncologist,2011

5. What is triple-negative breast cancer?;WJ Irvin Jr;Eur J Cancer,2008

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cáncer de mama triple negativo, receptor de andrógeno y otros marcadores. Estrategias terapéuticas;Revista de Senología y Patología Mamaria;2024-07

2. Research Progress on Predictive Indicators of Response to Neoadjuvant Chemotherapy for Breast Cancer;Advances in Clinical Medicine;2024

3. Radiomic Signatures Based on Mammography and Magnetic Resonance Imaging as New Markers for Estimation of Ki-67 and HER-2 Status in Breast Cancer;Journal of Computer Assisted Tomography;2023-07-24

4. Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type;Cancers;2023-04-08

5. Clinicopathological features and androgen receptor expression in triple negative breast cancer at Lagos, Nigeria;ecancermedicalscience;2022-10-03